Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Trial Identifier: D933AC00005
Sponsor: AstraZeneca
Start Date: June 2023
Primary Completion Date: November 2025
Study Completion Date: November 2025
Condition: Liver Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aomori, Japan
Japan Ehime, Japan
Japan Fukushima, Japan
Japan Iwate, Japan
Japan Kagawa, Japan
Japan Kyoto, Japan
Japan Nagasaki, Japan
Japan Nara, Japan
Japan Shiga, Japan
Japan Shimane, Japan
Japan Tochigi, Japan
Japan Yamaguchi, Japan